No price history available.
Key financial summary
Financials in INR| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | TTM | 2027E | ||
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | INRm | 2,971 | 3,575 | 6,079 | 6,681 | 5,936 | 6,685 | 8,300 | N/A | N/A |
| Operating profit | INRm | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net profit | INRm | 120 | 215 | 523 | 679 | 579 | 61 | 253 | N/A | N/A |
| EPS reported | INR | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Operating cashflow per share | INR | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Capex per share | INR | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF per share | INR | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Free cash flow | INRm | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net debt | INRm | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Book value equity | INRm | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Book value per share | INR | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Number of shares | m | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| DPS (TTM paid) | INR | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
Financial summary
Financials in INR| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | TTM | 2027E | ||
|---|---|---|---|---|---|---|---|---|---|---|
| Value | ||||||||||
| P/E LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| P/B LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| P/S LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| P/FCF LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| EV/EBITDA LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| EV/Sales LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Earnings Yield LTM | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF Yield | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Quality | ||||||||||
| ROE | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| ROIC | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Operating margin | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Gross margin | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF/Sales | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Growth and momentum | ||||||||||
| EPS Growth YoY | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Sales Growth YoY | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net Income Growth YoY | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF Growth | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Operating Profit Growth | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Dividend and capital structure | ||||||||||
| Dividend Yield | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Dividend Growth | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Payout Ratio | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF/Debt | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net Debt/EBITDA | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| EBIT/Net interest | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net debt/market cap | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net debt/Equity | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Gross debt/equity | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
Ratings
Based on consensus from external analysts. Not Kvantra's opinion.
Company overview
Yasho Industries Limited, an Indian company headquartered in Mumbai since its inception in 1985, specializes in manufacturing and supplying a comprehensive range of chemicals. Its market presence extends across the United States, Europe, Asia, and the Middle East. The company's product lines include a wide array of specialty and aroma chemicals, such as fatty esters and natural essential oils, essential for sectors like personal care, cosmetics, toiletries, flavors and fragrances, agrochemicals, dentifrices and oral care, and pharmaceuticals. For the food sector, Yasho offers various antioxidant chemicals, including tertiary-butyl hydroquinone, butylated hydroxy anisole, and ascorbyl palmitate, which are vital for preserving the quality of oil and fat-containing food items. In the rubber industry, it supplies accelerators and antioxidants, finding applications in tires, automotive components, general industrial products, and latex articles. Its portfolio also encompasses lubricant additives like aminic antioxidants, molybdenum-based compounds, anti-wear agents, and corrosion inhibitors, catering to both petroleum and synthetic lubricant manufacturers. Beyond these, Yasho also produces specialized chemicals tailored for diverse applications including electroplating, as intermediates for active pharmaceutical ingredients (APIs) and bulk drugs, for unsaturated polyester resins (UPRs) and fiber composites, thermoplastic urethanes, printing inks, and agrochemical formulations.
Similar companies
For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.
Yasho Industries Limited (YASHO.NS)
No price history available.
Based on consensus from external analysts. Not Kvantra's opinion.
Yasho Industries Limited, an Indian company headquartered in Mumbai since its inception in 1985, specializes in manufacturing and supplying a comprehensive range of chemicals. Its market presence extends across the United States, Europe, Asia, and the Middle East. The company's product lines include a wide array of specialty and aroma chemicals, such as fatty esters and natural essential oils, essential for sectors like personal care, cosmetics, toiletries, flavors and fragrances, agrochemicals, dentifrices and oral care, and pharmaceuticals. For the food sector, Yasho offers various antioxidant chemicals, including tertiary-butyl hydroquinone, butylated hydroxy anisole, and ascorbyl palmitate, which are vital for preserving the quality of oil and fat-containing food items. In the rubber industry, it supplies accelerators and antioxidants, finding applications in tires, automotive components, general industrial products, and latex articles. Its portfolio also encompasses lubricant additives like aminic antioxidants, molybdenum-based compounds, anti-wear agents, and corrosion inhibitors, catering to both petroleum and synthetic lubricant manufacturers. Beyond these, Yasho also produces specialized chemicals tailored for diverse applications including electroplating, as intermediates for active pharmaceutical ingredients (APIs) and bulk drugs, for unsaturated polyester resins (UPRs) and fiber composites, thermoplastic urethanes, printing inks, and agrochemical formulations.
